---
title: "NHS Framework Agreement for Branded Medicines - Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025"
ocid: "ocds-h6vhtk-04e273"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-04e273"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-04e273.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-04e273.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "NHS ENGLAND"
published: "2025-07-29"
---

# NHS Framework Agreement for Branded Medicines - Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025

Buyer: NHS ENGLAND  
Current stage: Award  
OCID: ocds-h6vhtk-04e273

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-04e273)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-04e273.json)

## Summary

NHS England has finalised a Framework Agreement titled "NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab" for pharmaceutical products. This procurement process, classified under CPV 33600000, is primarily concerned with goods for the healthcare industry and covers regions including London, North of England, and Midlands & East. The tender was executed under an open procurement method, and the agreement period extends from 01 September 2025 to 31 August 2027 for Lot 1, and 31 August 2026 for Lot 2. NHS England acted as the central purchasing body, and key framework suppliers were awarded contracts on 1 July 2025.

This procurement represents a significant opportunity for suppliers in the pharmaceutical industry to participate in a comprehensive supply chain managed by a major public health body. It allows manufacturers of branded medicines to collaborate with NHS England, ensuring a substantial presence in public healthcare procurement. Large-scale suppliers, as well as SMEs, could particularly benefit from the strategic position and steady demand this framework offers, with options to extend contracts providing further long-term growth prospects.

## Notice

NHS Framework Agreement for Branded Medicines - Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025
CM/PHR/24/5680/01 - Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 
CM/PHR/24/5680/02 - Eculizumab and Ravulizumab for London & SOFE. Period of Framework Agreement: 01 September 2025 to 31 August 2026

### Lot Information

Lot 1 - CM/PHR/24/5680/01 - Tranche B for North of England and Midlands & East

Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027. Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents.

Options: With an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Lot 2 - CM/PHR/24/5680/02 - Eculizumab and Ravulizumab for London & SOFE

Eculizumab and Ravulizumab for London & SOFE. Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents.

Options: With an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/043951-2025 |
| Notice type | Tender Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Large, SME |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 29 Jul 2025 |
| Submission deadline | 7 Apr 2025 |
| Future notice date | Not specified |
| Award date | 30 Jun 2025 |
| Contract period | 31 Aug 2025 - 31 Aug 2027 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £4,108,145,000 |
| Lots value | £2,874,717,000 |
| Awards value | Not specified |
| Contracts value | £1 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS ENGLAND |
| Locality | LEEDS |
| Post town | Leeds |
| Postcode | LS1 4AP |
| Country | England |
| ITL 1 | TLI London |
| ITL 2 | TLI4 Inner London - East |
| ITL 3 | TLI45 Lambeth |
| Local authority | Lambeth |
| Electoral ward | Waterloo & South Bank |
| Westminster constituency | Vauxhall and Camberwell Green |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 21 |
| Supplier names | ABBVIE; ACCORD-UK; ALEXION PHARMACEUTICALS; AMGEN; BIOGEN; CELLTRION HEALTHCARE UNITED KINGDOM; CURATEQ BIOLOGICS; DR.REDDY'S LABORATORIES (UK; FRESENIUS KABI; GLAXOSMITHKLINE; JANSSEN-CILAG; ORGANON PHARMACEUTICALS; ORIFARM; PFIZER; ROCHE PRODUCTS; SAMSUNG BIOEPIS; SANDOZ; SOBI (SWEDISH ORPHAN BIOVITRUM; TAKEDA; THORNTON AND ROSS; ZENTIVA PHARMA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 29 Jul 2025 at 14:34 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/043951-2025
- 17 Feb 2025 at 09:56 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/005287-2025

## Notice URLs

- http://health.atamis.co.uk
- https://health-family.force.com/s/Welcome
- https://supplierregistration.cabinetoffice.gov.uk
- https://www.england.nhs.uk/
- https://www.england.nhs.uk//
- https://www.judiciary.uk/courts-and-tribunals/high-court/

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-04e273. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-04e273.json.